Yutaka Kawakami
Affiliations: | Keio University, Minato-ku, Tōkyō-to, Japan |
Google:
"Yutaka Kawakami"Mean distance: 16.96 (cluster 17)
Children
Sign in to add trainee| Yohei Ohashi | research assistant | 2000-2004 | Keio University |
| Yukihiko Iizuka | grad student | 1999-2004 | Keio University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ohta S, Misawa A, Kyi-Tha-Thu C, et al. (2023) Melanoma antigens recognized by T cells and their use for immunotherapy. Experimental Dermatology |
| Morimoto Y, Tokumitsu A, Sone T, et al. (2022) TPT1 Supports Proliferation of Neural Stem/Progenitor Cells and Brain Tumor Initiating Cells Regulated by Macrophage Migration Inhibitory Factor (MIF). Neurochemical Research |
| Wang B, Xu Z, Sunthamala N, et al. (2022) Combinatorial sympathetic and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) blockades inhibit the murine melanoma growth by targeting infiltrating T cells. Translational Cancer Research. 10: 899-913 |
| Fukuda K, Okamura K, Riding RL, et al. (2021) AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma. The Journal of Experimental Medicine. 218 |
| Hirai I, Funakoshi T, Kamijuku H, et al. (2021) Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors. Cancer Science |
| Kinoshita T, Sayem MA, Yaguchi T, et al. (2021) Inhibition of vascular adhesion protein-1 enhances the anti-tumor effects of immune checkpoint inhibitors. Cancer Science |
| Yamada K, Hazama S, Suzuki N, et al. (2021) Siglec-7 is a predictive biomarker for the efficacy of cancer vaccination against metastatic colorectal cancer. Oncology Letters. 21: 10 |
| Hayakawa T, Yaguchi T, Kawakami Y. (2020) Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3. Cancer Science |
| Sugihara E, Hashimoto N, Osuka S, et al. (2020) The inhibitor of apoptosis protein Livin confers resistance to Fas-mediated immune cytotoxicity in refractory lymphoma. Cancer Research |
| Ohno A, Iwata T, Katoh Y, et al. (2020) Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy. Gynecologic Oncology |